Yaita Kenichiro, Yahara Koji, Hamada Nobuyuki, Sakai Yoshiro, Iwahashi Jun, Masunaga Kenji, Watanabe Hiroshi
Department of Infection Control and Prevention, Kurume University School of Medicine, Japan.
Department of Bacteriology II, National Institute of Infectious Diseases, Japan.
Intern Med. 2018 Apr 15;57(8):1071-1074. doi: 10.2169/internalmedicine.9405-17. Epub 2017 Dec 27.
Objective In 2010, candid advice concerning the low rate of typhoid vaccination among Japanese travelers was received from Nepal. Recently, progressive Japanese travel clinics have encouraged Japanese travelers to be vaccinated against typhoid fever in conjunction with officially approved vaccines, such as hepatitis A vaccine. We herein report the status of typhoid vaccinations for Japanese travelers to the most endemic area (South Asia) and describe the factors associated with compliance. Methods In the travel clinic at Kurume University Hospital, we used the following criteria to retrospectively extract the records of new pre-travel Japanese clients between January 2011 and March 2015: hepatitis A vaccine administered, traveling to South Asian countries, and ≥2 years of age. We first summarized the participants and then divided them into typhoid-vaccinated and typhoid non-vaccinated groups for a comparative analysis. Results This study included 160 clients. A majority (70.0%) of these clients traveled for business. The duration of trips was long (≥1 month) (75.0%), and India was a popular destination (90.6%). A comparative study between the vaccinated group (n=122) and the non-vaccinated group (n=38) revealed that the two factors most positively associated with typhoid vaccination were business trips [adjusted odds ratio (aOR) 3.59, 95% confidence interval (CI) 1.42-9.06] and coverage by a company/organization payment plan (aOR 7.14, 95% CI 2.67-20.3). Conclusion The trend toward typhoid vaccination among Japanese travelers to South Asia with pre-travel consultation is correlated with business trips and coverage by a company/organization payment plan. If problems concerning the cost of vaccines were resolved, more travelers would request typhoid vaccination.
目的 2010年,尼泊尔就日本旅行者伤寒疫苗接种率低的问题提出了坦率的建议。最近,一些先进的日本旅行诊所鼓励日本旅行者结合甲型肝炎疫苗等官方批准的疫苗接种伤寒疫苗。我们在此报告前往伤寒最流行地区(南亚)的日本旅行者的伤寒疫苗接种情况,并描述与接种依从性相关的因素。方法 在久留米大学医院的旅行诊所,我们使用以下标准回顾性提取2011年1月至2015年3月期间新的旅行前日本客户的记录:接种甲型肝炎疫苗、前往南亚国家以及年龄≥2岁。我们首先对参与者进行了总结,然后将他们分为接种伤寒疫苗组和未接种伤寒疫苗组进行比较分析。结果 本研究包括160名客户。这些客户中的大多数(70.0%)因公出差。旅行时间较长(≥1个月)(75.0%),印度是热门目的地(90.6%)。接种组(n=122)和未接种组(n=38)之间的比较研究表明,与伤寒疫苗接种最密切相关的两个因素是商务旅行[调整后的优势比(aOR)3.59,95%置信区间(CI)1.42 - 9.06]和公司/组织支付计划覆盖(aOR 7.14,95%CI 2.67 - 20.3)。结论 接受旅行前咨询的前往南亚的日本旅行者中,伤寒疫苗接种趋势与商务旅行以及公司/组织支付计划覆盖相关。如果疫苗成本问题得到解决,更多旅行者会要求接种伤寒疫苗。